Last reviewed · How we verify
DW6013
At a glance
| Generic name | DW6013 |
|---|---|
| Also known as | Linagliptin and Metformin |
| Sponsor | Dong Wha Pharmaceutical Co. Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- DW6013 CI brief — competitive landscape report
- DW6013 updates RSS · CI watch RSS
- Dong Wha Pharmaceutical Co. Ltd. portfolio CI